SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Nuvo Research Inc -- Ignore unavailable to you. Want to Upgrade?


To: TheBusDriver who wrote (8872)2/22/2002 8:50:07 AM
From: Ron Nairn  Read Replies (1) | Respond to of 14101
 
Dimethaid plans rapid response to Health Canada issues on PENNSAID(R) new drug submission

TORONTO, Feb. 7 /CNW/ - Dimethaid Research Inc. (TSE: DMX) announced today.....

The Company fully expects to respond in writing to all issues raised within 15 days.

THAT's TODAY Folks IMO

Rondo



To: TheBusDriver who wrote (8872)2/22/2002 11:38:19 AM
From: Montana Wildhack  Read Replies (1) | Respond to of 14101
 
It's my own fault.

The profile is there for all to see and as a long term
holder I have no excuse not to understand that until
DMX proves and reaffirms several times that its profile
has changed - we will have a continuation of the 2 year
pattern of moving up on news/anticipation and then drift
off until the next one.

Tough at times to seperate my overinformed/inlovewith
appraisals of the future from the stock behaviour
information I already have.

To me this is interesting because it is precisely the wedge
where emotion meets evaluation...but, not in the way we
might think.

I bought to hold with a target area above $20. If that's
the truth then a buck more or less paid becomes immaterial.
If that's not true then why did I think it was when I made
the purchase?

Just human nature.

I can readily fix this by raising my sell price to $23.
Now I expect to make more money than if I'd bought at $3.50
and had a target of $20. (GIGGLE)

Good luck everyone.

Wolf